WallStreetZenWallStreetZen

NASDAQ: IOVA
Iovance Biotherapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

IOVA past revenue growth

How has IOVA's revenue growth performed historically?
Company
13,669.75%
Industry
71.12%
Market
17.66%
IOVA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IOVA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IOVA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IOVA earnings and revenue history

Current Revenue
$32.8M
Current Earnings
-$440.2M
Current Profit Margin
-1,343.3%

IOVA Return on Equity

Current Company
-65%
Current Industry
22.9%
Current Market
33.8%
IOVA's Return on Equity (-65%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IOVA announces earnings.

IOVA Return on Assets

Current Company
-50.8%
Current Industry
3.5%
IOVA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IOVA Return on Capital Employed

Current Company
-51.23%
Current Industry
21.4%
IOVA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IOVA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IOVA$32.77M-$405.72M-$440.22M+13,669.75%N/A
APGE$0.00-$117.79M-$118.49MN/AN/A
CLDX$8.30M-$147.12M-$150.22M+11.37%N/A
KYMR$88.55M-$152.45M-$157.85M+74.73%N/A
XENE$0.00-$195.50M-$199.06M-100.00%N/A
View Top Biotech Stocks

IOVA earnings dates

Next earnings date
Oct 30, 2024

Iovance Biotherapeutics Earnings & Revenue FAQ

What were IOVA's earnings last quarter?

On Invalid Date, Iovance Biotherapeutics (NASDAQ: IOVA) reported Q2 2024 earnings per share (EPS) of -$0.34, up 27.66% year over year. Total Iovance Biotherapeutics earnings for the quarter were -$97.10 million. In the same quarter last year, Iovance Biotherapeutics's earnings per share (EPS) was -$0.47.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.

What was IOVA's earnings growth in the past year?

As of Q3 2024, Iovance Biotherapeutics's earnings has grown year over year. Iovance Biotherapeutics's earnings in the past year totalled -$440.22 million.

What is IOVA's earnings date?

Iovance Biotherapeutics's earnings date is Invalid Date. Add IOVA to your watchlist to be reminded of IOVA's next earnings announcement.

What was IOVA's revenue last quarter?

On Invalid Date, Iovance Biotherapeutics (NASDAQ: IOVA) reported Q2 2024 revenue of $31.11 million up 12,969.75% year over year. In the same quarter last year, Iovance Biotherapeutics's revenue was $238.00 thousand.

What was IOVA's revenue growth in the past year?

As of Q3 2024, Iovance Biotherapeutics's revenue has grown 13,669.75% year over year. This is 13,598.63 percentage points higher than the US Biotechnology industry revenue growth rate of 71.12%. Iovance Biotherapeutics's revenue in the past year totalled $32.77 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.